Antibiotic
kanamycin Audio
kan·a·my·cin
Effect:
Cell Membrane Alteration; Decreased Protein Synthesis
May Prevent:
Bacterial Infections
May Treat:
Acinetobacter Infections; Escherichia coli Infections; Hepatic Encephalopathy; Klebsiella Infections; Mycobacterium Infections; Proteus Infections; Respiratory Tract Infections; Serratia Infections; Staphylococcal Infections
More Information:
ChemID; DrugBank; DailyMed; DrugInfo; PDR
Definitions related to kanamycin:
  • Aminoglycoside antibiotic complex effective against aerobic gram-negative bacilli and some gram-positive bacteria including mycobacteria.
    CRISP Thesaurus
    National Institutes of Health, 2006
  • An aminoglycoside antibiotic with antimicrobial property. Amikacin irreversibly binds to the bacterial 30S ribosomal subunit, specifically in contact with 16S rRNA and S12 protein within the 30S subunit. This leads to interference with translational initiation complex and, misreading of mRNA, thereby hampering protein synthesis and resulting in bactericidal effect. This agent is usually used for treatment of E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.
    NCI Thesaurus
    U.S. National Cancer Institute, 2021
  • Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.
    NLM Medical Subject Headings
    U.S. National Library of Medicine, 2021
Try this search on: Farlex, Merriam-Webster, Oxford Dictionary, or Wordnik

This content should not be used in place of medically-reviewed decision support reference material or professional medical advice. Some terms may have alternate or updated definitions not reflected in this set. The definitions on this page should not be considered complete or up to date.